ArticleActa dermato-venereologica2024

Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study.

Ida Vittrup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.